Monthly Archives: January 2016

What is acceptance of pain and why would anyone want it?

Greater acceptance of chronic pain is associated with fewer pain-related difficulties, such as distress and disability, and better quality of life. Pragmatically, however, the idea that one might want to be more “accepting” of chronic pain runs contrary to common sense. To help clarify this confusion the McAuley Group, which researches low back pain at NeuRA, is proud to be […]

Read more

Volunteer for schizophrenia clinical trial

Volunteer call out: Canakinumab adjunctive treatment to reduce symptoms and improve cognition in people with schizophrenia displaying elevated blood inflammatory markers What is the purpose of the study? You are invited to participate in a research study of a human immune cell-line antibody upon language, memory, and symptoms of schizophrenia. This human immune cell-line antibody, canakinumab, is a class of […]

Read more

Everything our body does requires muscles, a brain and nerves

NeuRA’s Motor Impairment Group investigates this system and why it fails. The Motor Impairment Program is a five-year (2014-2018), NHMRC-funded grant, the goal of which is to better understand the pathophysiology of motor impairment, to implement interventions and to drive enhanced clinical practice. Following are highlights of the 2015 year. NeuRA’s Motor Impairment Research Program conducted a randomised controlled trial […]

Read more